Injective (INJ) is currently trading at $5.69, reflecting a modest 24-hour change of 0.81%. The price has fluctuated between a high of $5.83 and a low of $5.41 within the last day, indicating a daily range of 0.42%, which suggests relatively stable trading activity.

Volume stands at approximately 70.7 million, translating to a Vol/Market Cap ratio of 12.41%, indicating healthy trading interest. The hourly moving averages present mixed signals; the 8 and 13 SMA are slightly negative at -0.12% and -0.30%, respectively, while the 21 SMA shows a positive trend at +1.05%, suggesting potential upward momentum in the short term.

The 1-hour RSI is currently at 58, indicating a neutral to slightly bullish short-term momentum, while the 7-day RSI at 48 signals a lack of clear direction. Over the past week, the price has increased by 10.30%, reflecting some recovery, yet the 14-day change is slightly negative at -2.15%, hinting at a potential consolidation phase.

Longer-term, the 30-day price change shows a significant decline of -23.06%, reflecting bearish sentiment in the recent month. The all-time high of $52.62 achieved earlier this year remains a distant target, highlighting the challenges INJ faces to regain prior momentum.

Based on the current analysis, the mixed signals from moving averages and RSI metrics suggest cautious optimism, particularly in the short term. Therefore, I recommend a Hold rating, as the price shows potential for recovery but still faces significant resistance levels and underlying bearish trends over the longer timeframe.